Plain-English translation of NCT06645405 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an artificial intelligence (AI) software tool designed to help doctors better visualize and understand brain blood clots in patients having an acute stroke. The AI software automatically analyzes CT scan images to highlight the blocked blood vessel, which may help doctors navigate treatment more effectively. Researchers want to see if using this AI tool can improve outcomes for patients receiving emergency clot-removal procedures.
When patients have a stroke caused by a large blood clot in the brain, doctors need to remove it quickly using a minimally invasive procedure. However, it can be difficult for doctors to see exactly where the clot is and how to navigate through it safely. This trial exists to test whether the new AI software can make the blocked blood vessel clearer on imaging, potentially reducing treatment time and helping doctors avoid complications.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive standard stroke care as you normally would. Some hospitals in the study will use the new AI software to help analyze your brain imaging, while others will use standard methods during the first phase—then all hospitals will transition to using the AI tool. Your doctors will make all treatment decisions based on their clinical evaluation and what they see on the images, just as they always do. The study simply tests whether the AI-enhanced imaging helps doctors work more efficiently.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China